Cargando…
Peritoneal ultrafiltration in end-stage chronic heart failure
BACKGROUND: Cardiorenal syndrome type 2 (CRS-2) is common in end-stage chronic heart failure (CHF). Peritoneal ultrafiltration (pUF) may entail clinical functional improvement and a reduction in hospitalizations. METHODS: Thirty-nine consecutive end-stage CHF patients with stable CRS-2 were initiate...
Autores principales: | Fröhlich, Hanna, Katus, Hugo A., Täger, Tobias, Lossnitzer, Nicole, Grossekettler, Leonie, Kihm, Lars, Zeier, Martin, Remppis, Andrew, Frankenstein, Lutz, Schwenger, Vedat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370307/ https://www.ncbi.nlm.nih.gov/pubmed/25815181 http://dx.doi.org/10.1093/ckj/sfv007 |
Ejemplares similares
-
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
por: Grossekettler, Leonie, et al.
Publicado: (2020) -
Peritoneal dialysis as therapeutic option in heart failure patients
por: Grossekettler, Leonie, et al.
Publicado: (2019) -
When is contrast-enhanced sonography preferable over conventional ultrasound combined with Doppler imaging in renal transplantation?
por: Zeisbrich, Markus, et al.
Publicado: (2015) -
Recompensation of Heart and Kidney Function after Treatment with Peritoneal Dialysis in a Case of Congestive Heart Failure
por: Kihm, Lars P., et al.
Publicado: (2011) -
N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
por: Schnorbach, Johannes, et al.
Publicado: (2019)